Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials

K. M. Chin, S. Bartolome, K. Miller, C. Blair, H. Gillies, F. Torres

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences